MyAverix Finance
SHE · Healthcare
Nanjing Hicin Pharmaceutical Co Ltd (300584)
Drug Manufacturers - Specialty & Generic
Nanjing Hicin Pharmaceutical Co Ltd (300584) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $5.42B, P/E ratio is 122.11, net margin is 7.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 300584
Nanjing Hicin Pharmaceutical Co Ltd (300584) — FAQ
What is Nanjing Hicin Pharmaceutical Co Ltd's market cap?
Nanjing Hicin Pharmaceutical Co Ltd (300584) has a reported market cap of $5.42B (data as of 2026-03-28).
What is 300584's P/E ratio?
The price-to-earnings (P/E) ratio for Nanjing Hicin Pharmaceutical Co Ltd (300584) is 122.11 (data as of 2026-03-28).
Does Nanjing Hicin Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Nanjing Hicin Pharmaceutical Co Ltd (300584). Check the MyAverix Finance app for the latest dividend data.
What sector is Nanjing Hicin Pharmaceutical Co Ltd in?
Nanjing Hicin Pharmaceutical Co Ltd (300584) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 300584 listed on?
300584 is listed on SHE.
What is Nanjing Hicin Pharmaceutical Co Ltd's net margin?
Nanjing Hicin Pharmaceutical Co Ltd (300584) reports a net margin of 7.3% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.